Two Sigma Investments’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$256K Sell
228,405
-13,467
-6% -$15.1K ﹤0.01% 2798
2025
Q1
$191K Sell
241,872
-55,234
-19% -$43.6K ﹤0.01% 2803
2024
Q4
$490K Sell
297,106
-162,459
-35% -$268K ﹤0.01% 2487
2024
Q3
$1.61M Sell
459,565
-560,422
-55% -$1.96M ﹤0.01% 1750
2024
Q2
$3.35M Buy
1,019,987
+754,987
+285% +$2.48M 0.01% 1154
2024
Q1
$1.95M Sell
265,000
-1,285,659
-83% -$9.44M ﹤0.01% 1445
2023
Q4
$5.8M Sell
1,550,659
-100,613
-6% -$376K 0.01% 852
2023
Q3
$3.5M Sell
1,651,272
-266,273
-14% -$564K 0.01% 1016
2023
Q2
$9.13M Buy
1,917,545
+114,462
+6% +$545K 0.02% 639
2023
Q1
$10.3M Buy
1,803,083
+299,333
+20% +$1.71M 0.03% 553
2022
Q4
$15.2M Buy
1,503,750
+1,314,683
+695% +$13.3M 0.05% 412
2022
Q3
$4.24M Buy
+189,067
New +$4.24M 0.01% 790
2022
Q1
Sell
-14,700
Closed -$860K 2725
2021
Q4
$860K Sell
14,700
-284,842
-95% -$16.7M ﹤0.01% 1728
2021
Q3
$17.8M Buy
299,542
+6,467
+2% +$383K 0.04% 437
2021
Q2
$25.4M Sell
293,075
-366,508
-56% -$31.8M 0.06% 351
2021
Q1
$54.4M Buy
659,583
+337,241
+105% +$27.8M 0.14% 146
2020
Q4
$29.3M Sell
322,342
-46,582
-13% -$4.24M 0.08% 247
2020
Q3
$14.7M Buy
368,924
+151,961
+70% +$6.07M 0.05% 327
2020
Q2
$7.44M Buy
+216,963
New +$7.44M 0.04% 413
2020
Q1
Sell
-26,482
Closed -$518K 2067
2019
Q4
$518K Sell
26,482
-42,739
-62% -$836K ﹤0.01% 1690
2019
Q3
$1.08M Buy
+69,221
New +$1.08M ﹤0.01% 1172
2019
Q2
Sell
-177,404
Closed -$3.12M 2170
2019
Q1
$3.12M Sell
177,404
-150,471
-46% -$2.64M 0.01% 994
2018
Q4
$4.21M Sell
327,875
-134,494
-29% -$1.73M 0.02% 784
2018
Q3
$7.53M Buy
462,369
+289,524
+168% +$4.72M 0.02% 649
2018
Q2
$1.96M Buy
172,845
+82,141
+91% +$931K 0.01% 1078
2018
Q1
$885K Sell
90,704
-79,932
-47% -$780K ﹤0.01% 1369
2017
Q4
$1.04M Buy
+170,636
New +$1.04M ﹤0.01% 1452
2016
Q2
Sell
-61,141
Closed -$110K 2094
2016
Q1
$110K Buy
61,141
+41,195
+207% +$74.1K ﹤0.01% 1991
2015
Q4
$67K Buy
19,946
+7,646
+62% +$25.7K ﹤0.01% 1963
2015
Q3
$66K Buy
+12,300
New +$66K ﹤0.01% 1572